Search
for
Sort by
Research 631–660 of 1000+
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- Menopause and aging, quality of life and sexuality
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Polycystic Ovary Syndrome: A Common But Often Unrecognized Condition
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Sulfatase inhibitors: a patent review
- Hormonal treatment of acne vulgaris: an update
- Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin
- Female type of adult acne: Physiological and psychological considerations and management
- Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Hair loss and herbs for treatment
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Studying the genetic predisposing factors in the pathogenesis of acne vulgaris
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Redefining hormone resistance in prostate cancer
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial